(Q48369775)

11 February 2018

review article

1 reference

title

Alzheimer's drug design based upon an invertebrate toxin (anabaseine) which is a potent nicotinic receptor agonist. (English)

1 reference

11 February 2018

0 references

W R Kem

1

1 reference

11 February 2018

publication date

1 September 1997

1 reference

11 February 2018

Invertebrate Neuroscience

published in

1 reference

11 February 2018

volume

3

1 reference

11 February 2018

page(s)

251-259

1 reference

11 February 2018

issue

2-3

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/bf02480382

exact match

0 references

cites work

Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease.

1 reference

12 December 2020

Anabaseine: venom alkaloid of aphaenogaster ants

1 reference

12 December 2020

Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients.

1 reference

12 December 2020

Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice.

1 reference

12 December 2020

Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection

1 reference

12 December 2020

Nicotinic agonist modulation of neurotransmitter levels in the rat frontoparietal cortex.

1 reference

12 December 2020

Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents

1 reference

12 December 2020

Sites and mechanisms for nicotine's action in the brain

1 reference

12 December 2020

[3H]N-methyl-carbamylcholine, a new radioligand specific for nicotinic acetylcholine receptors in brain

1 reference

12 December 2020

A study of the occurrence of anabaseine in Paranemertes and other nemertines

1 reference

12 December 2020

Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain

1 reference

12 December 2020

Isolation and structure of a hoplonemertine toxin

1 reference

12 December 2020

Hoplonemertine worms—a new source of pyridine neurotoxins

1 reference

12 December 2020

Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21.

1 reference

12 December 2020

Nicotinic acetylcholine binding sites in Alzheimer's disease.

1 reference

12 December 2020

A nicotinic agonist (GTS-21), eyeblink classical conditioning, and nicotinic receptor binding in rabbit brain.

1 reference

12 December 2020

Pharmacokinetics and urinary excretion of DMXBA (GTS-21), a compound enhancing cognition.

1 reference

12 December 2020

Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors

1 reference

12 December 2020

Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes.

1 reference

12 December 2020

Nicotinic cholinergic system involvement in eyeblink classical conditioning in rabbits.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02480382

1 reference

11 February 2018

PubMed ID

9783447

1 reference

11 February 2018